Study of Low Level Laser Therapy for Body Contouring

NCT ID: NCT00738426

Last Updated: 2020-02-10

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

72 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-10-31

Study Completion Date

2008-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether green diode low level laser therapy is effective for body contouring of the waist, hips and thighs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Weight loss and body contouring are large, constantly-growing fields of cosmetic surgery. According to the American Society of Plastic Surgeons (ASPS) statistics, more than 324,000 liposuction procedures, 233,000 eyelid surgeries and 114,000 facelift procedures were performed in 2004 in the United States alone. However, while the demand for body shaping procedures is constantly on the rise, so is the demand for such procedures to be performed more quickly, simply and most importantly, less invasively. Cosmetic surgery patients are no longer satisfied with procedures that require general anesthesia, pose a multitude of potentially serious risks and complications and that require several weeks of recovery time. Hence the growing popularity of non- to minimally-invasive cosmetic surgery procedures. In 2005, more than 7.5 million minimally-invasive cosmetic procedures were performed, a 35% increase from 2000. Consequently, patients and physicians alike are continually searching for non-invasive alternatives to traditional cosmetic procedures such as liposuction that are efficient, safe and effective.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Body Contouring

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Erchonia ML Scanner (MLS)

Red diode low level laser light energy

Group Type ACTIVE_COMPARATOR

Erchonia ML Scanner (MLS)

Intervention Type DEVICE

Red diode low level laser light energy.

Sham device

non-therapeutic sham light output

Group Type SHAM_COMPARATOR

Sham device

Intervention Type DEVICE

non-therapeutic light energy output

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Erchonia ML Scanner (MLS)

Red diode low level laser light energy.

Intervention Type DEVICE

Sham device

non-therapeutic light energy output

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* indicated for liposuction for the removal of localized deposits of adipose tissues that do not respond to diet and exercise; specifically in the areas of the waist, hips and bilateral thighs.
* willing and able to abstain from partaking in any treatment other than the study procedure (existing or new) to promote body contouring and/or weight loss during the course of study participation.
* willing and able to maintain regular diet and exercise regimen without during study participation.
* 18 to 65 years.
* Male or female.

Exclusion Criteria

* Body Mass Index (BMI) of 30 kg/m² or greater.
* Diabetes dependent on insulin or oral hypoglycemic medications.
* known cardiovascular disease.
* cardiac surgeries, pacemakers.
* excessive alcohol consumption.
* prior surgical intervention for body sculpting/weight loss.
* medical, physical, or other contraindications for body sculpting/weight loss.
* current use of medication(s) known to affect weight levels and/or to cause bloating or swelling and for which abstinence during the course of study participation is not safe or medically prudent.
* medical condition known to affect weight levels and/or to cause bloating or swelling.
* diagnosis of, and/or taking medication for, irritable bowel syndrome.
* active infection, wound or other external trauma to the areas to be treated with the laser.
* pregnant, breast feeding, or planning pregnancy prior to study end.
* serious mental health illness; psychiatric hospitalization in past two years.
* developmental disability or cognitive impairment that would preclude adequate comprehension of the informed consent form and/or ability to record the necessary study measurements.
* involvement in litigation and/or a worker's compensation claim and/or receiving disability benefits related to weight-related and/or body shape issues.
* participation in research in the past 90 days.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Erchonia Corporation

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gregory C Roche, MD, FACS

Role: PRINCIPAL_INVESTIGATOR

Robert F Jackson, MD, FACS

Role: PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Douglas D. Dedo, MD, FACS

Palm Beach Gardens, Florida, United States

Site Status

Cosmetic Surgery

Marion, Indiana, United States

Site Status

Dr. Gregory C. Roche

Bloomfield Hills, Michigan, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

BCL-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

LLLT to Reduce Low Back Pain
NCT06007976 RECRUITING NA
Metabolism Enhancement by Laser Therapy
NCT06899958 NOT_YET_RECRUITING NA